Healthcare

Alpha Tau Medical is developing Alpha DaRT, a targeted radiation platform for solid tumors. The appeal comes from a differentiated approach, a large oncology market, and multiple potential milestone events that could reshape its commercial profile over time.

CONMED makes surgical devices used in orthopedics and minimally invasive procedures. Its appeal comes from recurring procedure-driven demand, solid cash generation, and exposure to outpatient surgery growth, while execution and debt reduction remain central to the long-term picture.

Hemab Therapeutics is a pre-revenue rare-disease biotech targeting severe bleeding and thrombotic disorders. Its appeal centers on focused hematology programs, rising development activity, and a balance sheet with low debt and meaningful cash support.

Compass Pathways is developing COMP360, a late-stage psilocybin therapy for treatment-resistant depression. Its relevance comes from a large unmet medical need, visible Phase 3 milestones, and an early lead in a new area of mental health treatment.

Certara provides software and scientific services that help drug developers model, test, and support medicines more efficiently. Its niche in biosimulation, recurring software mix, and steady cash generation make it a company worth examining closely.

Alignment Healthcare is a Medicare Advantage insurer that has expanded rapidly, turned free cash flow strongly positive, and moved close to sustained profitability. The appeal lies in its focused senior-care model and visible operating improvement as scale builds.